Skip to Content

WPI MINOCYCLINE 75 (Minocycline Hydrochloride 75 mg)

Pill with imprint WPI MINOCYCLINE 75 is White & Yellow, Capsule-shape and has been identified as Minocycline Hydrochloride 75 mg. It is supplied by Watson Pharmaceuticals.

Minocycline is used in the treatment of bacterial infection; acne; actinomycosis; bartonellosis; bullous pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI MINOCYCLINE 75

Minocycline hydrochloride 75 mg WPI MINOCYCLINE 75 Front
Minocycline hydrochloride 75 mg WPI MINOCYCLINE 75 Back
Minocycline hydrochloride 75 mg WPI MINOCYCLINE 75
Minocycline hydrochloride 75 mg WPI MINOCYCLINE 75

Minocycline Hydrochloride

Imprint
WPI MINOCYCLINE 75
Strength
75 mg
Color
White & Yellow
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Tetracyclines
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-3153
Inactive Ingredients
magnesium stearate, corn starch, D&C Red No. 28, D&C Yellow No. 10, gelatin, silicon dioxide, sodium lauryl sulfate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.